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Abstract
Objective: To describe the recruitment of patients, assessment instruments, implementation, methods and preliminary results of The 
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders, which includes seven university sites. Method: This cross-
sectional study included a comprehensive clinical assessment including semi-structured interviews (sociodemographic data, medical and 
psychiatric history, disease course and comorbid psychiatric diagnoses), and instruments to assess obsessive-compulsive (Yale-Brown 
Obsessive-Compulsive Scale and Dimensional Yale-Brown Obsessive-Compulsive Scale), depressive (Beck Depression Inventory) and 
anxious (Beck Anxiety Inventory) symptoms, sensory phenomena (Universidade de São Paulo Sensory Phenomena Scale), insight (Brown 
Assessment Beliefs Scale), tics (Yale Global Tics Severity Scale) and quality of life (Medical Outcome Quality of Life Scale Short-form-36 and 
Social Assessment Scale). The raters’ training consisted of watching at least five videotaped interviews and interviewing five patients with 
an expert researcher before interviewing patients alone. The reliability between all leaders for the most important instruments (Structured 
Clinical Interview for DSM-IV, Dimensional Yale-Brown Obsessive-Compulsive Scale, Universidade de São Paulo Sensory Phenomena 
Scale) was measured after six complete interviews. Results: Inter-rater reliability was 96%. By March 2008, 630 obsessive-compulsive 
disorder patients had been systematically evaluated. Mean age (±SE) was 34.7 (±0.51), 56.3% were female, and 84.6% Caucasian. 
The most prevalent obsessive compulsive symptom dimensions were symmetry and contamination. The most common comorbidities were 
major depression, generalized anxiety and social anxiety disorder. The most common DSM-IV impulsive control disorder was skin picking. 
Conclusion: The sample was composed mainly by Caucasian individuals, unmarried, with some kind of occupational activity, mean age 
of 35 years, onset of obsessive-compulsive symptoms at 13 years of age, mild to moderate severity, mostly of symmetry, contamination/
cleaning and comorbidity with depressive disorders. The Brazilian Research Consortium on Obsessive-Compulsive Spectrum Disorders 
has established an important network for standardized collaborative clinical research in obsessive-compulsive disorder and may pave 
the way to similar projects aimed at integrating other research groups in Brazil and throughout the world. 
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Resumo
Objetivo: Descrever o recrutamento de pacientes, instrumentos de avaliação, métodos para o desenvolvimento de estudos colaborativos 
multicêntricos e os resultados preliminares do Consórcio Brasileiro de Pesquisa em Transtornos do Espectro Obsessivo-Compulsivo, 
que inclui sete centros universitários. Método: Este estudo transversal incluiu entrevistas semi-estruturadas (dados sociodemográficos, 
histórico médico e psiquiátrico, curso da doença e diagnósticos psiquiátricos comórbidos) e instrumentos que avaliam os sintomas do 
transtorno obsessivo-compulsivo (Escala para Sintomas Obsessivo-Compulsivos de Yale-Brown e Escala Dimensional para Sintomas 
Obsessivo-Compulsivos de Yale-Brown), sintomas depressivos (Inventário de Depressão de Beck), sintomas ansiosos (Inventário de 
Ansiedade de Beck), fenômenos sensoriais (Escala de Fenômenos Sensoriais da Universidade de São Paulo), juízo crítico (Escala de 
Avaliação de Crenças de Brown), tiques (Escala de Gravidade Global de Tiques de Yale) e qualidade de vida (questionário genérico de 
avaliação de qualidade de vida, Medical Outcome Quality of Life Scale Short-form-36 e Escala de Avaliação Social). O treinamento dos 
avaliadores consistiu em assistir cinco entrevistas filmadas e entrevistar cinco pacientes junto com um pesquisador mais experiente, antes 
de entrevistar pacientes sozinhos. A confiabilidade entre todos os líderes de grupo para os instrumentos mais importantes (Structured 
Clinical Interview for DSM-IV, Dimensional Yale-Brown Obsessive-Compulsive Scale, Universidade de São Paulo Sensory Phenomena 
Scale ) foi medida após seis entrevistas completas. Resultados: A confiabilidade entre avaliadores foi de 96%. Até março de 2008, 630 
pacientes com transtorno obsessivo-compulsivo tinham sido sistematicamente avaliados. A média de idade (±SE) foi de 34,7 (±0,51), 
56,3% eram do sexo feminino e 84,6% caucasianos. Os sintomas obsessivo-compulsivos mais prevalentes foram os de simetria e os de 
contaminação. As comorbidades psiquiátricas mais comuns foram depressão maior, ansiedade generalizada e transtorno de ansiedade 
social. O transtorno de controle de impulsos mais comum foi escoriação neurótica. Conclusão: Este consórcio de pesquisa, pioneiro no 
Brasil, permitiu delinear o perfil sociodemográfico, clínico e terapêutico do paciente com transtorno obsessivo-compulsivo em uma grande 
amostra clínica de pacientes. O Consórcio Brasileiro de Pesquisa em Transtornos do Espectro Obsessivo-Compulsivo estabeleceu uma 
importante rede de colaboração de investigação clínica padronizada sobre o transtorno obsessivo-compulsivo e pode abrir o caminho 
para projetos semelhantes destinados a integrar outros grupos de pesquisa no Brasil e em todo o mundo.
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Introduction
Obsessive-compulsive disorder (OCD) is a common and disabling 
disorder.1 Despite the increasing number of studies investigating 
aspects of OCD clinical characteristics, genetics, neuroimaging 
and treatment response, the pathogenesis of the disorder remains 
unknown, and a substantial number of patients do not respond to 
available treatments.2,3 
One of the most frequent constraints that limit the progress of 
OCD research is the relatively small number of patients enrolled in 
most studies, which contributes to reducing the statistical power 
and to limiting interpretation of findings. 
Therefore, patient recruitment and proper evaluation is a 
fundamental step for the development of clinical research. However, 
this is not always an easy task. There are patients who do not 
accept participating or do not look for treatment for reasons related 
to intrinsic characteristics of the condition. These include features 
such as fear, embarrassment, lack of insight, symptom severity and 
specific presentations of obsessive-compulsive symptoms (OCS). All 
of them implicate in more limited access to patients.  
Another challenge is to perform a comprehensive evaluation in a 
great number of patients. Detailed phenotypic interviews are very time-
consuming and need careful training of several reliable interviewers 
to be administered to a substantial number of subjects. 
One strategy to overcome these limitations and optimize 
recruitment and training efforts is multicenter collaborations between 
research groups, also called consortiums. This type of initiative, 
usually limited to a specific research area, has already been applied 
to several psychiatric disorders, including schizophrenia4 and 
bipolar disorders.5 There are no published studies using this type 
of approach in OCD. 
The purpose of this study is to present initial findings of The 
Brazilian Research Consortium on Obsessive-Compulsive Spectrum 
Disorders (CTOC), an enterprise of seven Brazilian centers aiming 
to investigate characteristics of OCD patients and their families, 
spanning over all areas of OCD research.
More precisely, this paper provides a detailed description 
of the CTOC implementation and its methodology, including 
recruitment of patients, assessment instruments, quality assurance 
procedures and the inter-rater reliability process. We also present 
the demographic and clinical characteristics of the initial 630 
patients evaluated. 
 
Method
1. Ethical issues 
CTOC research projects were submitted to and approved by 
the local Ethics Committees of the involved centers (Process: 
USP-968/05; IPA-6600023; UFRGS-06/171; Unifesp-302/2006 
and UFRJ-0024.0.249.000-06). Written informed consents were 
obtained from all participants, after a thorough description of the 
objectives and methods of each study, and the reassurance that 
their decision to participate or not would not have any impact on 
their treatment availability. When the subject was younger than 
18 years old, a written informed consent form was signed by the 
subject and also by a parent or legal guardian. 
2. CTOC organization and structure
The CTOC was created in 2003. It has a self-governing 
organizational structure to facilitate the establishment of group 
policies and procedures. There are sub-committees for different 
issues, as shown in Figure 1. 
a) Universidade de São Paulo (USP); b) Universidade Federal de São Paulo (Unifesp); c) Universidade Estadual Paulista (Unesp); d) Universidade Federal do Rio 
de Janeiro (UFRJ); e) Universidade Federal do Rio Grande do Sul and Universidade Metodista do Sul - Instituto Porto Alegre (UFRGS-IPA); f) Universidade Federal 
de Pernanbuco (UFPE); g) Universidade Federal da Bahia (UFBA). OCD - Transtorno Obsessivo-Compulsivo
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The main objectives of the CTOC are to systematically collect 
clinical data of OCD patients from multiple centers, building a 
database for collaborative studies; to stimulate the development 
of expert groups in this field throughout the country; to share 
information and to set up a higher standard of care for Brazilian OCD 
patients; to promote research training in this field; to create, translate, 
adapt and validate instruments to assess OCD; and to generate new 
findings that can contribute to the understanding and treatment of 
OCD and the most common psychiatric comorbidities.
Since 2006, the CTOC has been sponsored mainly by the National 
Council for Scientific and Technological Development (CNPq, i.e., 
the Millennium Project), but also by grants from Fundação de 
Amparo à Pesquisa do Estado de São Paulo (Fapesp). 
A website was created to facilitate the communication between 
members (http://protoc.incubadora.fapesp.br/portal/ctoc/). At this 
restricted website, assessment instruments, videos for interview 
training and inter-rater reliability assessment, tasks, workshop 
planning and other information are available online.
3. Description of each center 
Brazil is a country with continental dimensions and great cultural 
diversity. It has 26 states, divided into five regions, and a current 
population of almost 190 million inhabitants (Brazilian Institute of 
Geography and Statistics – IBGE, 2008, available at http//:www.
ibge.org.br). Each region has its own culture, ethnic distribution, 
and socioeconomic characteristics. In order to contemplate this 
diversity, the CTOC is composed of seven centers from five Brazilian 
states and three different regions (Table 1). 
This cross-sectional study is the result of the recruitment of the 
first three years (from 2005 to 2007). CTOC structure and principles 
allow each center to have independent research projects in different 
fields, such as the phenotype dissection of OCD heterogeneity, 
genetics, neuropsychology, neuroimaging and clinical trials with 
pharmacotherapy, cognitive-behavioral therapy and neurosurgery 
for refractory cases. Each leading team may invite researchers from 
other centers to participate as co-authors, so that several projects 
are currently underway.
4. Implementation of the CTOC 
The analyses of the variables originated from the instruments listed 
bellow will be planned for each new research project, according to 
the specific characteristics and objectives of the various studies to 
be conducted with this database. All future studies using the CTOC 
dataset will be based on predefined hypotheses.
1) Assessment instruments 
Initially, the leaders from each center gathered in two different 
occasions to decide which instruments should be included in the 
“Initial Evaluation Protocol” and to nominate researchers for each 
of the sub-committees. The current version of the ”Initial Evaluation 
Protocol” is an assessment package (available at http://protoc.
incubadora.fapesp.br/portal/ctoc/) that includes an informed consent 
form, sociodemographic, socioeconomic (according to Associação 
Brasileira de Institutos de Pesquisa de Mercado – ABIPEME - scale), 
medical history data, a semi-structured interview about family 
psychiatric history (available under request), and the instruments 
briefly described below. The research protocol is usually completed 
over the course of one to three meetings (2 to 3 hours each), which 
are scheduled with intervals as short as possible. Each center 
may add instruments to this basic research protocol, according to 
approved specific projects.
2) Clinical assessment
Structured Clinical Interview for DSM-IV (SCID-I)6 and additional 
modules for tic and impulse control disorders.7 Attention deficit 
hyperactivity disorder (ADHD) and separation anxiety disorder are 
investigated through a module of the Kiddie Schedule for Affective 
Disorders and Schizophrenia (K-SADS).8
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Yale-Brown Obsessive-Compulsive Scale (Y-BOCS).9 This scale 
has been used worldwide to evaluate OCS severity. It has been 
translated into Portuguese by Asbhar et al., 2002.
Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-
BOCS).10 It evaluates OCS according to specific dimensions, which 
include obsessions and related compulsions. The severity of each 
dimension can be independently quantified. Another advantage of 
this scale is that avoidant behaviors, mental and repetitive rituals 
are investigated within each dimension, allowing for a more precise 
evaluation of the severity of patients’ symptoms. It also investigates 
the time spent with OCS, the level of anxiety and interference, with 
scores ranging from 0 to 5 (maximum of 15 for each dimension). 
The negative impact of OCS is also measured (maximum score of 
30) and the therapeutic response can be evaluated according to 
specific dimensions. This instrument was simultaneously validated 
in Portuguese and English.
Yale OCD Natural History Questionnaire (Leckman et al., 2002, 
unpublished manuscript, translated into Portuguese by Rosário 
et al., 2002). This is a detailed instrument about  OCS onset 
and course, including several life events and situations that may 
contribute to trigger, worsen or improve symptoms. 
Yale Global Tic Severity Scale (YGTSS).11 This scale has been used 
worldwide to evaluate the nature and severity of motor and vocal 
tics. Translated into Portuguese by Miguel et al., 2000.
Beck Depression and Anxiety Inventories.12,13 Translated into 
Portuguese by Gorenstein and Andrade, 1996.14 These are widely 
known scales to evaluate depressive and anxiety symptoms. 
Universidade de São Paulo Sensory Phenomena Scale 
(USP-SPS).15 The USP-SPS evaluates the presence and severity 
of sensory phenomena (SP - subjective experiences of physical or 
mental sensations associated with repetitive behaviors). It is a semi-
structured scale composed by two parts. The first one investigates 
the occurrence of past and current SP, divided into physical and 
mental sensations (examples of each type are supplied), including 
age at onset. The second part measures the frequency, distress 
and interference caused by each SP, in Likert scales ranging from 
0 to 4 or 5.
Multimodality Treatment Assessment Study - Swanson, Nolan 
and Pelham Questionnaire (SNAP – IV) for parents and teachers 
(translated into Portuguese by Mattos et al., 2006).16 This scale 
evaluates symptoms of hyperactivity and attention deficit. 
Brown Assessment of Beliefs Scale (BABS).17 Translated into 
Portuguese by Ferrão and Hounie, 2002. The BABS is a clinician-
administered scale to evaluate different aspects of the patient’s 
insight: conviction regarding the belief, perception of others’ views and 
explanation of different views about it, fixity of belief, attempts to disprove 
it, whether the individual recognizes a psychiatric/psychological cause 
for the belief, and presence of ideas of reference. 
Social Assessment Scale (SAS). Translated into Portuguese by 
Gorenstein et al., 2002.18 This 42-item scale evaluates the quality 
of nine areas of participants’ social life: work (three areas), leisure, 
family, marital status, offspring, domestic life and financial status. 
Brazilian version of the Medical Outcomes Study Short Form 
36 (SF-36). Translated and validated to Portuguese by Ciconelli et 
al., 1999.19 The SF-36 evaluates the quality of life in the previous 
month and consists of 11 items, subdivided into 36 questions. It 
comprises questions about physical, social and emotional health, 
regarding different activities and general limitation. 
Clinical Global Impressions Scale (CGI, adapted version).20 The 
CGI investigates the health professional’s impression regarding the 
patient’s problem severity. 
5. Training of the Interviewers and CTOC meetings
In order to guarantee a standardized use of the instruments, 
experienced clinicians trained the personnel from all the centers. 
A PhD level psychologist from Universidade de São Paulo (USP) 
visited the other CTOC sites to conduct training sessions on the 
application of structured interviews, which had already been used 
at USP. In addition, since 2003, two-day meetings have been held 
three times a year to discuss, practice and standardize the utilization 
of the research instruments (13 meetings so far). 
Workshops on specific issues were also organized in order 
to present research results, discuss new research projects and 
specific methodological aspects. Brazilian experts on several areas 
(e.g. immunology, genetics, neuroimaging, neuropsychology, 
psychopathology of other disorders, statistics, database, etc.) have 
been invited to improve the discussions. 
During every CTOC meeting, a videotaped interview with a 
patient, including the SCID-I, DY-BOCS and USP-SPS interviews, 
was watched by all participants, who rated their evaluations using 
individual answer sheets that were inserted in a specific database 
for reliability evaluations. Nine meetings with this aim have already 
been organized so far. As this is an ongoing consortium project, live 
and videotaped interviews will be continuously rated by participants 
for reliability purposes (at least twice a year). 
Interviews using the above cited instruments, conducted by 
experienced professionals, are also available at the CTOC website, 
facilitating new members’ training. Training consists of watching at 
least five videotaped interviews, observing five live interviews and 
interviewing five patients with the supervision of another researcher 
before interviewing patients alone. Instructions about the use of the 
most important instruments are also available at the CTOC website, 
as well as the most frequent doubts and questions regarding the use 
of these scales. In case of remaining questions about interviews, the 
Assessment Instruments sub-committee can be consulted. 
The leaders also promote continuous training in their centers to 
guarantee a high level of reliability among the participants of the 
local research teams.
All research protocols are sent to the Central Data Core (USP) 
and are thoroughly reviewed for quality assurance before insertion 
in the CTOC database. This is performed by a psychologist (MAM) 
who has directly participated in the training of members from all 
centers. She extensively checks all the files to detect possible missing 
or incongruent data. When found, the protocol is returned to the 
original site for correction (if necessary, the patient is reinterviewed). 
After insertion, the data are also reviewed by the Database sub-
committee, constituted by six members. Copies of the research 
protocols are stored locally at each center. The final database is 
available for each center leader (Figure 1). 
6. Types of studies
1) Phenotypical studies
These are the core projects conducted by the CTOC, since 
all centers use the “Initial Evaluation Protocol” that has all 
the phenotypic information. Based on the clinical assessment 
instruments, several studies on the phenotypical expression of 
OCD are being conducted or being prepared, including gender 
differences, early vs. late onset of symptoms, specific comorbidity 
patterns (e.g. patients with and without tic disorders, substance 
use and impulse control disorders, and social anxiety disorder) 
and specific clinical features of some symptom dimensions (e.g. 
hoarding obsessions and compulsions), presence of suicidal 
thoughts, plans and attempts, etc.
CTOC assessment instruments and methods
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2) Other studies
Performed by some of the centers, depending on their specificities, 
investigating the following aspects: a) Genetic Studies (the CTOC 
is part of an international consortium for genetic studies in OCD). 
Blood serum and DNA from blood or saliva are also obtained from 
patients and first-degree relatives to perform molecular genetics 
and immunological investigations); b) Neuroimaging studies, 
investigating cerebral structural and functional alterations; c) 
Neuropsychological studies, investigating brain function as possible 
endophenotypes; d) Clinical trials, investigating the response to 
pharmacological or cognitive-behavioral approaches. 
7. Sample recruitment 
Until March 2008, a total of 630 patients had been systematically 
evaluated and included in the dada set. 
Inclusion criteria: individuals under treatment in any of the seven 
sites, who had DSM-IV OCD as their main psychiatric diagnosis 
confirmed by the SCID-I,6 and were able to understand and agreed 
to participate in the research protocol. 
Forty-six patients from all centers were excluded from the study: 
seven patients fulfilled DSM-IV diagnostic criteria for schizophrenia; 
one patient was unable to understand and provide informed consent 
and 38 subjects refused to participate: 32 due to the long time 
spent to answer all the research protocol, and six did not agree to 
sign the informed consent (two were afraid of being identified, and 
four did not want to supply blood for genetic research).
Sources of referral included outpatient (mostly) and inpatient 
clinics, clinicians in primary or secondary health care units, private 
psychiatric services (150 from São Paulo and 20 from Rio Grande 
do Sul), websites, media advertisements, self-help groups and 
the Brazilian Association of Obsessive-Compulsive and Tourette 
Syndrome Disorders (ASTOC – www.astoc.org.br). Recruitment 
efforts were focused on individuals living in the local area or patients 
presenting for treatment at the centers. 
8. Statistical analyses
Initially, the frequency and distribution calculations of selected 
variables were performed for the sample as a whole, using mean ± 
standard error (SE), percentages, median, minimum and maximum 
values. For the differences between centers, Pearson’s chi-square for 
categorical (dichotomic or polytomic) variables was used. Tests were 
adjusted for all pairwise comparisons within a row of each innermost 
suitable using the Bonferroni correction. One-way analysis of variance 
(ANOVA) followed by the post-hoc Scheffé test (normal distribution) 
or Kruskal-Wallis H test (non-normal distribution) for continuous 
variables were performed. Scales scores (e.g. Y-BOCS, DY-BOCS, 
BABS, BDI, BAI, YGTSS) were analyzed as continuous variables. 
The initial objective of this study was to measure the inter-rater 
reliability between the leaders of all CTOC centers with at least 
six patients thoroughly evaluated. As it is an ongoing consortium 
work, the reliability analyses will be continuously performed every 
ten cases. At this moment, for an initial reliability evaluation, only 
the core instruments for most studies and those that could lead to 
higher occurrence of disagreement between evaluators were chosen. 
It must be highlighted that the inter-reliability was not assessed 
for those scales that are very descriptive (straightforward answers) 
CTOC assessment instruments and methods
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and less clinical, with little room for disagreement. Furthermore, 
all participants watched the videos together and discussed each 
of the differences. 
The statistical level of significance adopted was 5%. The software 
used in all analyses was the Statistical Package for Social Science 
(SPSS), version 15.0 (SPSS Inc., Chicago, USA).
Results 
1. Inter-rater reliability
Concerning the reliability of instrument administration between 
raters, the leaders of each center watched and independently rated at 
least six patients’ videotaped interviews of the SCID-I, DY-BOCS and 
USP-SPS, totalizing 191 items, which were analyzed. The answers 
could be dichotomic or ordinal. Of these 191 items, 184 (96%) 
were concordant by the eight leaders of the research centers. Three 
items (1.6%) were discordant for one rater, three items (1.6%) for 
two raters and one item (0.5%) for four raters. 
2. Demographic and clinical data 
Of the 630 patients, 308 (49.0%) came from USP, 126 (20.0%) 
from Universidade Federal do Rio Grande do Sul-Universidade 
Metodista do Sul (UFRGS-IPA), 73 (11.6%) from Universidade 
de Pernambuco (UPE), 49 (7.8%) from Universidade Estadual 
Paulista (Unesp), 33 (5.2%) from Universidade Federal de São 
Paulo (Unifesp), 23 (3.7%) from Universidade Federal da Bahia 
(UFBA), and 17(2.7%) from Universidade Federal do Rio de Janeiro 
(UFRJ). Table 2 shows the main sociodemographic and clinical 
features for the total sample and of each of the centers. Having no 
partner was more frequent at the UPE center and the lowest rates 
of unemployment appeared at the UFRGS-IPA center. The sample 
evinces a higher prevalence of social class A at the USP center 
(reflecting the higher frequency of private patients in this center) and 
social class E at UFBA. Higher mean educational level was found 
at USP (also secondary to the higher frequency of private patients 
in this center). The age at onset of OCS was higher for the Unesp 
center, and the longest time gap to start any kind of appropriate 
treatment occurred at UFRGS-IPA. According to Y-BOCS, DY-BOCS 
and CGI, the most severe cases were presented by the UFRGS-IPA 
and UPE centers.
Although it was not an initial purpose of this study, the 
sociodemographic and clinical characteristics of patients from 
private and public services were compared, since it was believed 
to be a potential confounding variable. The patients recruited from 
public services, when compared to private ones, were more likely 
to be female, from lower social class, less educated, and to present 
a longer time gap to start treatment. They also tended to be older 
when they get the OCD diagnosis and to have more severe OCS 
(measured by the Y-BOCS and DY-BOCS), as shown in Table 3. 
Prior to the interview, the most frequently used anti-obsessive 
medications were fluoxetine (n = 290, 46.0%); clomipramine 
(n = 220, 34.9%); paroxetine (n = 166, 26.3%), and sertraline 
(n = 166, 26.3%). The most frequently used benzodiazepines 
were clonazepam (n = 185, 29.4%), diazepam (n = 81, 12.9%), 
and alprazolam (n = 70, 11.1%), and the most frequently 
used antipsychotics associated with the SSRIs were risperidone 
(n = 61, 9.7%), haloperidol (n = 52, 8.3%), and olanzapine 
(n = 33, 5.2%). 
According to the DY-BOCS, the most prevalent symptom dimension 
was symmetry. The other dimensions are described in Figure 2. 
The most common “other OCS” were obsessions of separation 
from parents or other relatives (n = 248; 39.4%), superstitious 
obsessions (n = 226; 35.9%), obsessions about medical diseases 
(n = 203; 32.2%), “slowness, repetitive behaviors” (n = 202; 
32.1%), and compulsions to prevent from losing a relative 
(n = 201; 31.9%). The DY-BOCS dimensions median scores 
were (25th percentile-75th percentile): aggression – 4 (0-9); sexual-
religious – 0 (0-8); symmetry, order – 8 (3-11); contamination, 
cleaning – 7 (0-11); hoarding – 0 (0-6); other OCS – 8 (3-11) and 
total score – 22 (18-25). 
The lifetime psychiatric comorbidities are listed in Table 4. The 
five most common comorbidities were major depressive disorder, 
generalized anxiety disorder, social anxiety disorder (“social anxiety 
disorder” has been proposed as an alternative for the DSM-IV 
established term “social phobia”), simple phobia and separation 
anxiety (investigated in all sample, including adults). Among 
impulsive control disorders, skin picking appeared as the most 
common comorbidity followed by compulsive buying, intermittent 
explosive disorder and trichotillomania. Eating disorders were 
present in less than 10% of the sample, as well as drug/alcohol 
abuse or dependence and ADHD.  
The mean (±SE) age of the first tic was 12.87 (±0.62), ranging 
from 1 to 55 years old (median = 12.0). The USP-SPS was 
administered to 605 subjects; 395 (65.3%) of them presented any 
of the sensory phenomena and the total mean (±SE) score of the 
scale was 7.81 (±0.17), ranging from 1 to 15.
The mean (±SE) score of BDI of 613 patients was 15.54 
(±0.45), ranging from 0 to 53 (median = 14); and of BAI was 
15.15 (±0.46), ranging from 0 to 53 (median = 13.0). Among 
the 593 patients that answered the BABS, the mean (±SE) score 
was 6.49 (± 0.22), ranging from 0 to 24 (median = 6). 
The quality of life of 378 patients of the sample (60.0%), 
according to the SF-36, showed the following scores [mean(±SE)]: 
functional capacity: 83.79 (±1.04); limitation due to physical 
aspects: 75.19 (±1.71); pain: 71.79 (±1.37); general health 
status: 64.00 (±1.27); vitality: 52.84 (±1.18); social aspects: 
49.93 (±1.51); limitation due to emotional aspects: 53.00 
(±1.88); mental health: 53.98 (±1.11). A total SF-36 score 
could be obtained through the arithmetic mean of the eight 
dimensions: 63.14 (±0.96). According to the EAS scores, the 
mean (±SE) total score was 1.40 (±0.042) for those patients 
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who work (n = 234); 1.73 (±0.041) for those who are 
housewives (n = 211); and 0.99 (±0.045) for those who are 
students (n = 95).
Discussion 
There is considerable agreement on the need to recruit a 
high number of participants for clinical research on psychiatric 
disorders in general and OCD in particular. Large sample sizes 
enhance the study power to test specific hypotheses. We present 
the first CTOC investigating characteristics of OCD patients and 
their families spanning over all areas of OCD research. The 
main objective of the CTOC is to conduct multicenter research 
on OCD, using properly and uniformly administered assessment 
instruments in order to form a unique dataset to be used by 
all Consortium sites. These requirements entail a great deal of 
planning, mainly to standardize the training and methods, and 
to constantly guarantee cross-site reliability. Considering the 
remarkable heterogeneity of OCD, this approach optimizes the 
findings on specific clinical phenotypes of the disorder, which 
is extremely relevant for clinical, genetic, neuropsychological, 
neuroimaging and treatment outcome studies. 
So far, our research assessment protocol has proved to be 
successful. The interviews exhibited adequate inter-rater reliability, 
an essential step for a multicenter initiative like this. The continuing 
regular meetings have allowed CTOC members to “test” the 
applicability of the assessment package and to identify current or 
potential problems. This strategy also favored the clarification of 
several clinical questions and the immediate correction of some 
quandaries, including unclear decision trees or imprecise statements. 
Nevertheless, the current absence of appropriate validation of the 
instruments in Brazil may, to some extent, limit some findings of 
our studies. As it is an ongoing research Consortium, future papers 
will acknowledge this core methodological aspect.
After the first two years of active recruitment, 630 participants 
(much more than the predefined goal) have been successfully 
evaluated and their data inserted in the core data bank. Some 
caution on the external validity of all studies derived from this sample 
should be taken. All CTOC centers are specialized university services 
or private clinics for OCD treatment, probably comprising more 
severe cases. Therefore, the results cannot be directly generalized to 
OCD patients from primary or secondary health care units, neither 
to community samples. 
It is also uncertain to what extent the results can be generalized 
to other countries and cultures, despite the similar profile of 
the main OCD clinical features worldwide.21 In Brazil, only two 
community-based studies (restricted to big urban areas) have 
been conducted. The lifetime prevalence rates of OCD found in 
the general population were 0.7% in Brasilia-DF, 2.1% in Porto 
Alegre-RS22 and 0.3% in São Paulo-SP.23 Most surveys conducted 
in other countries and cultures have found lifetime prevalence 
ranging from 0.3% to 3.0%.24 Although these quite distinct 
estimates may reflect methodological differences among sites, 
such as different interviewers’ training and skills, they are more 
likely due to some regional differences in a country with so much 
cultural variety.24,25 
Nevertheless, the CTOC sample includes patients from different 
Brazilian states and regions and the patients’ demographic and 
clinical characteristics differ in many aspects between the centers, 
as indicated by the initial comparative analysis reported here. 
Otherwise the sample ethnic distribution resembles the Brazilian 
cultural heterogeneity (Brazilian Institute of Geography and Statistics, 
2008-IBGE, available at http//:www.ibge.org.br), since the centers 
from the Northeast region, in contrast with the centers from the 
South, present lower frequency of Caucasian participants. 
This CTOC sample also includes patients from private and 
public services. The longer time gap to start treatment in the 
public services, when compared to the private ones, may indicate 
deficiencies in the current public health system in the identification 
and management of OCD cases. Considering the level of education, 
as measured by the number of years of formal education, the two-
year difference found between these groups, although statistically 
significant, does not seem to be clinically relevant. It is worthwhile 
to stress that even the participants from public services had a 
much higher level of education compared to the Brazilian general 
population, which ranges from 4.6 years in the Northeast to 6.6 
years in the Southeast region (Brazilian Institute of Geography 
and Statistics, 2008-IBGE, available at http//:www.ibge.org.br). 
Therefore, a possible difference on the capacity to understand the 
assessment instruments by individuals from private and public 
services is very unlikely. Furthermore, participants with considerable 
difficulties in understanding the research questions were excluded 
from the study.
Although the YBOCS and D-YBOCS showed statistically significant 
differences between public and private participants, one point in 
the YBOCS compulsions subscale and 1.4 points in the D-YBOCS 
total score do not seem to evince clinical relevance.
This is the first study with a large sample to evaluate OCS 
using a dimensional questionnaire (DY-BOCS). The results are 
CTOC assessment instruments and methods
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similar to other two previously published papers with 48 and 137 
patients,2,10 which indicated the dimension of symmetry, order 
and arrangement as the most prevalent one. Another instrument 
evaluating subjective experiences of physical or mental sensations 
associated with repetitive behaviors (sensory phenomena) – the 
USP-SPS – was also widely used for the first time. The prevalence 
of sensory phenomena in this sample (65.3%) was similar to that 
of other studies, where they ranged from 40% to 57.5%.1,15,26-28 The 
mean score on BDI and BAI were consonant with other international 
studies,29 but lower than one previous Brazilian study.30 The BABS 
mean score was similar to that found by Phillips et al. in 198 OCD 
patients: 6.8 (±4.9).31
Our findings concerning comorbid axis I conditions are generally 
in the reported ranges for OCD clinical samples, which were 
differently ascertained and vary considerably. As in most studies, 
major depressive disorder was the most frequent comorbid condition, 
followed by anxiety disorders in general. In the literature, the rates 
for depressive episodes vary from 20-67%, for specific phobias from 
7%-22%, for social anxiety disorder from 8-42% and generalized 
anxiety disorder from 8-32%.32-38 The slightly higher figures for some 
disorders in our sample may be due to the fact that these patients 
are from specialized or tertiary services, which usually assist more 
severe cases. The 7.5% prevalence of alcohol dependence is similar 
to that of other clinical studies34,39 and much lower than that of 
community studies,40,41 as expected.
There are differences regarding the types of comorbid psychiatric 
disorders found in community and clinical samples, probably 
because of their impact on help-seeking behaviors.42 The CTOC 
sample presents a comorbidity pattern that is similar to what is 
expected in clinical studies. Lifetime prevalence of mood, anxiety 
and tic disorders are very similar to findings from previous studies 
with OCD patients who are under treatment.26,43 On the other hand, 
this study presents original findings regarding the prevalence of 
specific impulse control disorders that had never been systematically 
investigated in such a large sample. The relatively high frequency 
of comorbidity with skin picking and the relatively low frequency of 
compulsive sexual behavior, compulsive “interneting,” kleptomania 
and pathological gambling found in this sample may serve as an 
additional evidence suggesting that skin picking may be part of the 
obsessive-compulsive spectrum disorders44 as opposed to a more 
“impulsive spectrum,” which would include the other putative 
impulse control disorders.45,46 More studies in this area of OCSD are 
clearly needed. Addictive behaviors, such as those involved in drug 
and alcohol abuse and dependence are much less frequent in clinical 
samples, compared to general population samples, indicating that 
some OCD sufferers may be using substances to deal with their 
symptoms instead of seeking treatment.37
The results regarding some aspects of the patient’s quality 
of life (QoL) (i.e., vitality, social, emotional and mental health) 
reflect the negative impact of OCD severity and other co-occurring 
symptoms (i.e., depressive, anxious). The importance of studying 
this aspect is that QoL may be an appropriate indicator of treatment 
impact on several aspects of the patient’s life.47 Severe OCD 
symptoms may lead to the same levels of QoL and family burden 
of schizophrenic patients, especially on psychological and social 
domains.48 Even with relatively mild mean scores of depression 
and anxiety symptoms, their additional impact on OCD may 
increase the patient’s burden and, probably, of their families.25 
More specific analyses of QoL of these patients will be described 
in future papers, regarding clinical aspects that can have different 
impact, such as obsessions or compulsions, as suggested by 
Stengler-Wenzke et al.49
The CTOC participants are confident that their main goals 
have been successfully achieved so far. Relevant clinical data 
have been systematically and uniformly collected, a large 
database for collaborative studies has been built, graduate and 
post-graduate students are receiving research training in this 
field, and expert groups are under continuous development 
throughout the country. This effort will certainly generate new 
findings that can contribute to the understanding and treatment 
of OCSD, which hopefully will lead to a better standard of care 
for Brazilian patients and their families and may serve as a model 
to be followed in other countries.
In conclusion, the CTOC has established an important network for 
recruitment and implemented methods for standardized assessment 
of OCD patients in Brazil. In addition, the chosen instruments 
also allowed, for the first time, a comprehensive evaluation and 
measurement of multiple intrinsic and extrinsic OCD features in a 
large clinical sample. It was possible, for the first time in our country, 
to draw a general demographic and clinical profile of OCD patients 
from different regions: most of them are Caucasian, unmarried, 
with some kind of occupational activity, mean age of 35 years and 
onset of OCS at 13 years of age, symptoms of mild to moderate 
severity, higher prevalence of symmetry and contamination/cleaning 
symptoms and comorbidity with depression. The present findings 
provide a strong methodological backbone for the studies to come. 
Moreover, the CTOC may pave the way to similar projects aimed at 
integrating other Brazilian research groups.
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